Richard F. Riedel MD

Richard F. Riedel, MD, is an Associate Professor with Tenure in the Division of Medical Oncology at Duke University Medical Center and the Associate Director for Clinical and Translational Research for the Sarcoma Program at Duke Cancer Institute. He also serves as the Program Director for the Duke Hematology-Oncology Fellowship Program.

Dr. Riedel earned his medical degree from Jefferson Medical College. He subsequently completed his internal medicine residency, chief residency, and hematology/oncology fellowship at Duke University Medical Center.

Dr. Riedel’s clinical and research interests focus on identifying novel therapeutics for patients with soft tissue and bone sarcoma. He is an active participant in Sarcoma Alliance for Research through Collaboration (SARC) and serves on the medical advisory boards for the Sarcoma Foundation of America and the National Leiomyosarcoma Foundation. He is a member of the American Society of Clinical Oncology (ASCO) and the Connective Tissue Oncology Society (CTOS) and previously served as Chair of the ASCO Education Section for sarcoma. He is currently a member of the ALLIANCE Sarcoma Working Group and serves as Co-Chair for the ECOG Sarcoma Working Group.

Dr. Riedel is a member of the NCCN Soft Tissue Sarcoma Panel and the NCCN Gastrointestinal Stromal Tumors (GISTs) Panel.